Salani, Jumarija A.
HRN: 16-48-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2024
CEFUROXIME 500MG (TAB)
12/08/2024
12/14/2024
BID
500 Mg Tab
BID
SP NSVD W RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes